Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Protocol ID
OPTIMISE
Disease (Sub Disease)
Advanced brain tumours
Solid tumours
Diagnosis Stage
Relapse/refractory
Location
NSW, QLD
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
The Hospital for Sick Children
Children's Cancer Institute Australia (CCIA)
Medical Research Future Fund
Kazia Therapeutics Limited
Day One Biopharmaceuticals, Inc.
C17 Council
Trial Status
Open
Sites
Queensland Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
<21 years
International registry ID's
NCT06208657 (ClinicalTrials.gov)
Back to Registry
Study Title Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Protocol ID OPTIMISE
Disease (Sub Disease) Advanced brain tumours
Solid tumours
Diagnosis Stage Relapse/refractory
Location NSW / QLD
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Collaborators The Hospital for Sick Children/ Children's Cancer Institute Australia (CCIA) / Medical Research Future Fund / Kazia Therapeutics Limited / Day One Biopharmaceuticals, Inc. / C17 Council
Links https://clinicaltrials.gov/ct2/show/NCT06208657
Trial Status Open
Trial Open Date 10/07/2024
Sites Queensland Children's Hospital / Sydney Children's Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility <21 years
International registry ID's NCT06208657 (ClinicalTrials.gov)